These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27718234)

  • 1. Drug Transporters: Advances and Opportunities.
    Govindarajan R; Sparreboom A
    Clin Pharmacol Ther; 2016 Nov; 100(5):398-403. PubMed ID: 27718234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
    Mao Q; Lai Y; Wang J
    Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance.
    Zamek-Gliszczynski MJ; Taub ME; Chothe PP; Chu X; Giacomini KM; Kim RB; Ray AS; Stocker SL; Unadkat JD; Wittwer MB; Xia C; Yee SW; Zhang L; Zhang Y;
    Clin Pharmacol Ther; 2018 Nov; 104(5):890-899. PubMed ID: 30091177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to Reduce Solute Carrier-Mediated Toxicity.
    Hu S; Sprowl JA
    Clin Pharmacol Ther; 2018 Nov; 104(5):799-802. PubMed ID: 30028006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
    Feng B; Varma MV; Costales C; Zhang H; Tremaine L
    Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transporters in hepatic drug disposition: an update.
    Li P; Wang GJ; Robertson TA; Roberts MS
    Curr Drug Metab; 2009 Jun; 10(5):482-98. PubMed ID: 19689245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transporter-mediated tissue targeting of therapeutic molecules in drug discovery.
    Zhou J; Xu J; Huang Z; Wang M
    Bioorg Med Chem Lett; 2015 Mar; 25(5):993-7. PubMed ID: 25650254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Call for papers to theme issue on membrane transporters: an opportunity to boost transporter studies.
    Yuasa H
    Drug Metab Pharmacokinet; 2007 Dec; 22(6):399-400. PubMed ID: 18159126
    [No Abstract]   [Full Text] [Related]  

  • 9. Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.
    Evers R; Piquette-Miller M; Polli JW; Russel FGM; Sprowl JA; Tohyama K; Ware JA; de Wildt SN; Xie W; Brouwer KLR;
    Clin Pharmacol Ther; 2018 Nov; 104(5):900-915. PubMed ID: 29756222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane transporters in drug development.
    Keogh JP
    Adv Pharmacol; 2012; 63():1-42. PubMed ID: 22776638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of drug transporter interactions in drug discovery and development.
    Lai Y; Sampson KE; Stevens JC
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):112-34. PubMed ID: 20053160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.
    Schlessinger A; Welch MA; van Vlijmen H; Korzekwa K; Swaan PW; Matsson P
    Clin Pharmacol Ther; 2018 Nov; 104(5):818-835. PubMed ID: 29981151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug trafficking: recent advances in therapeutics and disease.
    Sprowl JA; Sparreboom A
    Clin Pharmacol Ther; 2012 Nov; 92(5):531-4. PubMed ID: 23085872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging transporters: Transforming diagnostic and therapeutic development.
    Mann A; Han H; Eyal S
    Clin Pharmacol Ther; 2016 Nov; 100(5):479-488. PubMed ID: 27327047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond drug-drug interactions: effects of transporter inhibition on endobiotics, nutrients and toxins.
    Lepist EI; Ray AS
    Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1075-1087. PubMed ID: 28847160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
    Zhou Q; Yu LS; Zeng S
    Drug Metab Rev; 2014 Aug; 46(3):283-90. PubMed ID: 24796860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
    Mooij MG; Nies AT; Knibbe CA; Schaeffeler E; Tibboel D; Schwab M; de Wildt SN
    Clin Pharmacokinet; 2016 May; 55(5):507-24. PubMed ID: 26410689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of Drug Transporters in Organ Toxicity: The Fundamental Basis of Drug Discovery and Development.
    Cheng Y; El-Kattan A; Zhang Y; Ray AS; Lai Y
    Chem Res Toxicol; 2016 Apr; 29(4):545-63. PubMed ID: 26889774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transporter assays as useful in vitro tools in drug discovery and development.
    Volpe DA
    Expert Opin Drug Discov; 2016; 11(1):91-103. PubMed ID: 26512742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption.
    Harwood MD; Neuhoff S; Carlson GL; Warhurst G; Rostami-Hodjegan A
    Biopharm Drug Dispos; 2013 Jan; 34(1):2-28. PubMed ID: 22927116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.